Correlation Between Candel Therapeutics and Protalix Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Protalix Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Protalix Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Protalix Biotherapeutics, you can compare the effects of market volatilities on Candel Therapeutics and Protalix Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Protalix Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Protalix Biotherapeutics.
Diversification Opportunities for Candel Therapeutics and Protalix Biotherapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Candel and Protalix is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Protalix Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protalix Biotherapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Protalix Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protalix Biotherapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Protalix Biotherapeutics go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Protalix Biotherapeutics
Given the investment horizon of 90 days Candel Therapeutics is expected to under-perform the Protalix Biotherapeutics. In addition to that, Candel Therapeutics is 1.0 times more volatile than Protalix Biotherapeutics. It trades about -0.05 of its total potential returns per unit of risk. Protalix Biotherapeutics is currently generating about 0.37 per unit of volatility. If you would invest 108.00 in Protalix Biotherapeutics on August 26, 2024 and sell it today you would earn a total of 61.00 from holding Protalix Biotherapeutics or generate 56.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Candel Therapeutics vs. Protalix Biotherapeutics
Performance |
| Timeline |
| Candel Therapeutics |
| Protalix Biotherapeutics |
Candel Therapeutics and Protalix Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Candel Therapeutics and Protalix Biotherapeutics
The main advantage of trading using opposite Candel Therapeutics and Protalix Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Protalix Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protalix Biotherapeutics will offset losses from the drop in Protalix Biotherapeutics' long position.| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |